BUSINESS● LOWAug 13 · Aug 13, 2026, 11:03 AM
VYNE Therapeutics GAAP EPS of -$2.14 misses by $1.92
Seeking Alpha Tech
VYNE Therapeutics reported its GAAP earnings per share, which were -$2.14. This figure missed expectations by $1.92.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoFifth Third expects 2.5%-3.5% Q4 net interest income growth as it targets $200M-$300M buybacksSeeking Alpha TechBUSINESS31m agoServisFirst outlines 5-7 bps quarterly margin expansion as it launches 2m-share repurchase planSeeking Alpha Tech